Article and Video CATEGORIES

Cancer Journey

Search By

Lung Cancer Video Library - Whole Brain Radiation for Brain Metastases
Author
GRACE Videos and Articles
Image
Radiation Oncologist Dr. Vivek Mehta reviews the concept of using whole brain radiation for multiple brain metastases, including how it is delivered and risks and benefits of this strategy.

 

Please feel free to offer comments and raise questions in our Discussion Forums.

 

Transcript

I see a number of patients that come into my clinic with brain metastases, a situation where cancer has spread to their brain. Unfortunately in lung cancer, cancer spreads to the brain quite commonly. The first thing that we do is we try to image the brain to evaluate how many lesions we might see. Often times there are many lesions — 2, 3, 4, 5, sometimes ten or more lesions. When you have a situation where you have several lesions in the brain, you worry that there may be more lesions that you can’t see, that are simply too small to be detected on the imaging studies that we’ve had. In that situation, the standard of care is to offer patients something called whole brain radiation (WBRT). 

Whole brain radiation often evokes fear in patients and their family members when they hear about this, because in principle what this is, is delivering radiation to the entire brain. What we do is we often give them a very low dose of radiation every day, Monday through Friday, over a period of a few weeks. There are various different schedules that you could use. Some people favor delivering this treatment over multiple visits, say over 20 visits in four weeks. Other people favor doing this over a shorter time interval, say ten treatments over two weeks. And of course there are always people in the middle that prefer a three week course of treatment. 

In the studies that have been done, probably all of these have the same effectiveness in terms of controlling the cancer. The issue is that as you spread it out over a longer period of time, you’re probably a little bit more gentle on the brain than you would be if you were doing it over a shorter period of time. The longer period of time also has one other problem associated with that, and that is that we typically don’t want to give chemotherapy or systemic therapies at the same time as we’re delivering whole brain radiation, so sometimes we’re trying to get that treatment done quicker so we can get patients back on chemotherapy or systemic therapy.

When we deliver the whole brain radiation, the patients come into our department, they lay on a table and they often get a treatment that lasts somewhere in the neighborhood of 10 or 15 minutes. It’s a low dose of radiation delivered to the entire brain contents. They don’t see anything, feel anything, hear anything, they don’t glow in the dark, they’re not radioactive, nothing like that. They can go home and they can be safe with their family members. But over the course of that treatment, there are certain side effects that can occur. Patients can get tired, they can get a little bit nauseated, sometimes they can lose their hair or get scalp irritation, they can get the stuffy sensation in their ears as if that earwax is sort of plugging them up. Most of these symptoms we can manage with simple medicines.

Most of these symptoms tend to resolve a few weeks after the treatment and go away, but there are long-term side effects associated with that radiation as well.  There could be permanent irreversible damage to the skin, the skull, the blood vessels, and the actual underlying brain parenchyma itself. Sometimes this long-term damage can actually manifest in terms of a significant deterioration in their quality of life. What I’m talking about is that there is a lot of data suggesting that there could be cognitive impairment from the radiation itself, or changes in their ability to think and mentate, or potentially even brain injury. This doesn’t happen very often, and this doesn’t happen very immediately, this tends to be a delayed effect of treatment. But this is a real but small risk, all that needs to be put in context of treating the underlying cancer. 

Untreated cancer in the brain has the risk of strokes, it has the risk of bleeds, is can cause neurologic compromise, people can become symptomatic from that. We don’t have a lot of very good alternatives to treating patients that have disease in their brain. If there are multiple spots we typically don't do surgery because there’s too many places where we would have to operate, and the surgeon can’t get to the highways and byways in between. We try not to give chemotherapy, because historically, chemotherapy hasn’t crossed the blood-brain barrier and in any sort of sufficient fashion in order to get rid of the cancer successfully every time. 

There are radiation techniques where you do pinpoint radiation just to certain spots in the brain, but they also don’t treat the spots in between, so often times we’re left with whole brain radiation. Over the years and the decades that we’ve been doing whole brain radiation, it’s been an effective treatment for many of these patients, and they tend to do well in terms of local control.

Now obviously, the bigger the size of tumor you have, the more symptomatic that you are, the less likely that this low dose of radiation of the whole brain will help sterilize everything, in which case there may be combinations that are employed: Whole brain radiation and pinpoint radiation, whole brain radiation and surgery, are some of the options that are used.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated. 
Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!
Image
Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón
Video
¡El vídeo completo bajo demanda está disponible para verlo!

Forum Discussions

Radiation + Brain Operation has just been discarded due to high risk. They will double Tagrisso dosis and then wait to see if it works, then try traditional Chemo. I would...

Hi and welcome to GRACE.  I'm sorry to know you are entering a new stage.  I'm not about to comment just now but wanted to let you know I see your...

Edit to say, we can't give advice but we can comment with views and facts.  :)

 

My first thought is to ask if she has been seen at a large...

Hi Barbro, Welcome to GRACE. I'm sorry you're worrying about this. We aren't able to give feedback on scan reports. Interpreting scan reports in this setting is not only unethical but...

Hi Miranda, I hope I can put your mind at ease. The reasons for your symptoms are numerous and a pancoast tumor is close the bottom of that list.  A lot...

Hello CRT, Welcome to GRACE.  I'm so sorry your husband's cancer is figuring out a work around tagrisso.  I'm sorry his onc hasn't been more communicative.  It's pretty standard to stay...

Thank you for your quick reply! What you mention about hospice makes sense.

And thank you for the link regarding other opinions.

My husband recently took a Guardant blood test but...

Recent Comments

JOIN THE CONVERSATION
My first thought is to ask…
By JanineT GRACE … on
Hi CRT, I wanted to share…
By JanineT GRACE … on
Hi and welcome to GRACE.  I…
By JanineT GRACE … on
Update
By APT_CL on